Trial Profile
Rilmenidine treatment in postmenopausal hypertensive women with metabolic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Rilmenidine (Primary)
- Indications Hypertension; Left ventricular hypertrophy
- Focus Therapeutic Use
- 02 Sep 2015 New trial record